XBiotech Inc. — Director's Dealing 2017

Jul 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2017-07-07

Reporting Person: Guzman Benjamin (Sr.VP Corp. Strategy & Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-07	Employee Stock Option	$4.78	A	300000	Acquired	2027-07-07	Common Stock (300000)	Direct

Footnotes

F1: The Options vest in 3 equal annual installments beginning on the first annual anniversary of the Grant Date (July 7, 2017).